A pilot study to evaluate paclitaxel (Taxol(TM)) as primary medical treatment for patients with inoperable stage III and IV breast carcinoma

European Journal of Cancer Part A

Volumn 32, Issue 13, 1996, Pages 2354-2356

  Rees, C N ^a   Sinnett, D ^a   Lowdell, C ^a   English, J ^a   Coombes, R C ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Breast carcinoma; Paclitaxel; Primary medical treatment

Indexed keywords

PACLITAXEL;

ADULT; ALOPECIA; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; STOMATITIS; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 0030446477     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00348-6     Document Type: Article

References (8)

1. 1. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979, 277, 665-667.
2. 2. Wani MC, Taylor HL, Wall ME, et al. Plant antitumour agents VI. The isolation and structure of Taxol, a novel antileukaemic and antitumour agent from Taxus brevifolia. J Am Chem Soc 1971, 93, 2325-2327.
3. 3. Rowinsky EK, Onetto N, Canetta RM, et al. Taxol: the first of the taxanes, an important new class of antitumour agents. Semin Oncol 1991, 19, 646-692.
4. 4. Holmes FA, Walters RS, Theriault RL, et al. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991, 83, 1797-1805.
5. 5. Gianni L, Munzone E, Capri G, et al. Paclitaxel in metastatic breast cancer: a trial of two doses by a 3 hour infusion in patients with disease recurrence after prior infusion with anthracyclines. J Natl Cancer Inst 1995, 87, 1169-1175.
6. 6. Spielman M. Taxol (paclitaxel) in patients with metastatic breast carcinoma who have failed prior chemotherapy: interim results of a multinational study. Oncology 1994, 51(Suppl. 1), 25-28.
7. 7. Reichman BS, Seidman AD, Crown JP, et al. Paclitaxel and recombinant human granulocyte colony stimulating factor as an initial chemotherapy for metastatic breast cancer. J Clin Oncol 1993, 11, 1943-1951.
8. 8. Seidman AD, Norton L, Reichman BS, et al. Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony stimulating factor in the treatment of breast cancer. Semin Oncol 1993, 20(Suppl. 3), 40-45.